Immune-mediated approaches against COVID-19

Area of Science:

• Virology
• Immunology
• Nanotechnology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, characterized by a long, asymptomatic incubation period facilitating rapid global spread.
• The absence of a universally approved treatment for COVID-19 underscores the urgent need for therapeutic and vaccine development.
• Knowledge from prior infectious disease outbreaks is being leveraged for drug repurposing and vaccine research.

Purpose of the Study:

• To review the pathogenesis of SARS-CoV-2.
• To examine immune-mediated therapeutic strategies for COVID-19.
• To highlight the role of nanotechnological tools in developing COVID-19 vaccines and therapeutics.

Main Methods:

• Literature review of SARS-CoV-2 pathogenesis.
• Analysis of immune-mediated treatment approaches for COVID-19.
• Exploration of nanodelivery systems in vaccine and therapeutic design.

Main Results:

• Understanding SARS-CoV-2 infection mechanisms and host immune responses is crucial for targeted interventions.
• Nanoscale delivery systems are identified as key components for successful prophylactic and therapeutic strategies.
• Various immune-mediated approaches are under investigation for COVID-19 treatment.

Conclusions:

• Further research into SARS-CoV-2 infection and immunity is essential for designing effective, mass-producible vaccines and therapeutics.
• Nanotechnology holds significant potential for advancing COVID-19 treatment and prevention strategies.
• A comprehensive understanding of pathogenesis and immune responses will guide the development of specific and efficient interventions.